CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended		53 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011
CASH FLOW FROM OPERATING ACTIVITIES
Net loss	$ (1,559,294)	$ (1,419,092)	$ (8,744,696)
Adjustments to reconcile net loss to net cash used in operating activities
Amortization	157,490	145,962	737,243
Common stock issued for services			300,000
Stock options and warrants	363,562	428,748	2,931,013
(Increase) decrease in assets
Grants receivable	244,479
Drug product for testing	88,400	77,262
Other current assets	20,967	(35,614)	(52,026)
Increase (decrease) in liabilities
Accounts payable and accrued expenses	(41,761)	(192,850)	204,997
Net cash used in operating activities	(726,157)	(995,584)	(4,623,469)
CASH FLOW FROM INVESTING ACTIVITIES
Purchase of exclusive license - related party	(62,547)	(175,437)	(752,201)
Net cash used in investing activities	(62,547)	(175,437)	(752,201)
CASH FLOW FROM FINANCING ACTIVITIES
Proceeds from convertible notes			435,000
Cash repayment of convertible notes			(15,000)
Net proceeds from sale of common stock	1,533,425	709,349	5,938,956
Net cash from financing activities	1,533,425	709,349	6,358,956
NET INCREASE/(DECREASE) IN CASH	744,721	(461,672)	983,286
Cash, beginning of period	238,565	567,249
Cash, end of period	983,286	105,577	983,286
Cash paid for
Interest
Income taxes
Non-cash financing activities
Common stock issued upon conversion of convertible notes			420,000
Placement Agent
Non-cash financing activities
Common stock issued	179,421	117,300	564,266
Related Party Transactions
Non-cash financing activities
Common stock issued			2,354,167
Lincoln Park Capital Fund, LLC
Non-cash financing activities
Common stock issued		$ 202,580	$ 202,580